BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Familial history is the primary risk factor for ovarian cancer (OC).
• Germline BRCA1 mutations, like 185delAG, are strongly linked to hereditary OC.
• The role of specific BRCA1 mutations in initiating OC pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the impact of the BRCA1 185delAG mutant (BRAT) on Interleukin-1β (IL-1β) expression in normal human ovarian surface epithelial (OSE) cells.
• To determine if BRAT expression promotes an inflammatory phenotype in OSE cells.
• To explore the regulatory mechanisms underlying BRAT-mediated IL-1β production.

Main Methods:

• Cultured OSE cells with and without BRAT expression.
• Real-time PCR and western blot for gene and protein expression analysis.
• ELISA for secreted IL-1β levels.
• Luciferase reporter assays for promoter activity.
• siRNA assays to assess inflammasome involvement.

Main Results:

• OSE cells expressing BRAT showed significantly increased cellular and secreted levels of active IL-1β.
• BRAT-mediated IL-1β mRNA expression was elevated 3-fold and transcriptionally regulated via CREB sites.
• BRAT enhanced IL-1β expression through inflammasome-mediated caspase-1 activation.

Conclusions:

• The BRCA1 185delAG mutant (BRAT) induces an inflammatory phenotype in OSE cells by upregulating IL-1β.
• BRAT-mediated IL-1β induction involves both transcriptional regulation and inflammasome activation.
• Increased IL-1β expression due to BRAT may be an early event in ovarian cancer development, warranting further mechanistic studies.